Cargando…
MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours
BACKGROUND: MED12 and TERT promoter mutations have been shown to be the most common somatic mutations in phyllodes tumours (PTs). The aims of this study were to determine the frequency of these mutations in recurrent PTs, assess whether TERT promoter mutations could be helpful in distinguishing fibr...
Autores principales: | Garcia-Dios, Diego A, Levi, Dina, Shah, Vandna, Gillett, Cheryl, Simpson, Michael A, Hanby, Andrew, Tomlinson, Ian, Sawyer, Elinor J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785756/ https://www.ncbi.nlm.nih.gov/pubmed/29315289 http://dx.doi.org/10.1038/bjc.2017.450 |
Ejemplares similares
-
TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast
por: Yoshida, Masayuki, et al.
Publicado: (2015) -
Frequent MED12 mutations in phyllodes tumours of the breast
por: Yoshida, M, et al.
Publicado: (2015) -
The TERT variant rs2736100 is associated with colorectal cancer risk
por: Kinnersley, B, et al.
Publicado: (2012) -
Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations
por: Otsuji, Kazutaka, et al.
Publicado: (2020) -
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways
por: Sitaram, R T, et al.
Publicado: (2010)